Swinburne University calls for industry to get behind drug-driving research

Swinburne University researchers are struggling to win industry support for a landmark study into medicinal cannabis and driving despite drug-driving laws being the “biggest barrier to patient access in Australia”. 

Research fellow at the university’s Centre for Human Psychopharmacology Dr Thomas Arkell told Cannabiz his team has recruited just four patients for the study so far, with 80 needed to sign up over the next 18 months.